More articles about: Rogel Cancer Center
Philanthropy News
Gifts advance colon cancer prevention and early detection
The Rose and Lawrence C. Page, Sr. Family Charitable Foundation supports lifesaving colon cancer research at Michigan Medicine.
Health Lab
Study explains how colorectal cancer cells maintain high iron levels
How colorectal cancer cells maintain high iron levels, according to Michigan Medicine research.
Health Lab
Receiving personalized treatment for a rare neuroendocrine tumor
Danielle Schuldt was diagnosed with a rare endocrine tumor and underwent surgery as part of her treatment. She now undergoes regular surveillance to monitor for cancer recurrence.
Health Lab
Phase 1 trial of alrizomadlin shows promise in targeting metastatic salivary gland cancers
University of Michigan researchers, in partnership with Ascentage Pharma, developed a drug known as alrizomadlin, or APG-115, to target metastatic salivary gland cancers.
Health Lab
New dual-target drug may help overcome immunotherapy resistance in pancreatic cancer
U-M researchers developed a new strategy to improve immunotherapy treatments for pancreatic cancer.
Department News
Meet the leader of the Rogel Cancer Center's Community Outreach & Engagement Program
In early 2026, Rachel Bergmans, Ph.D., MPH, was named as administrative director of the COE team. We sat down to get to know her better and what her goals are in her new role.
Cancer Aware
CAR T-cell Therapy
Using one's cells to attack and treat cancer continues to grow. Cellular therapy and in particular CAR T-cell therapy offers new opportunities to adult and pediatric patients with blood cancers like leukemia and lymphoma. Dr. Monalisa Ghosh, Rogel Cancer Center oncologist talks about these treatments and and the future of cellular therapy.
Health Lab
Thriving after a rectal cancer diagnosis
Kyle Kipke was diagnosed with rectal cancer and received chemotherapy and radiation as treatment at Michigan Medicine.
Health Lab
Diagnosed with pancreatic cancer: Now what?
A pancreas cancer surgeon explains from Michigan Medicine how to find the best place for treatment, why that matters, and what to expect from the process.
Health Lab
Doctors perform first liver transplant in Michigan for colon cancer
Andrew Sweeney was diagnosed with stage 4 colorectal cancer at age 31 and underwent a liver transplant, chemotherapy and radiation treatment.
Health Lab
FDA-approved cancer drug fedratinib reshapes how cell organelles communicate, providing new therapeutic avenues
University of Michigan researchers found that the FDA-approved drug fedratinib can lead to endoplasmic reticulum and mitochondria contact site formation, providing a potential therapeutic avenue.
Health Lab
Glucose drives STAT3 activation in colorectal cancer cells, leading to tumor growth
University of Michigan researchers have shown that glucose levels sustain the increased STAT3 activation in colorectal cancer cells. Their findings suggest that targeting glucose metabolism could inhibit STAT3, leading to novel therapeutic strategies.
Health Lab
Encapsulated ovarian donor tissue restores ovarian function in mice
University of Michigan researchers have demonstrated that donated ovarian tissue can produce natural hormone cycles in mice, with the aim of restoring female hormone cycles for pediatric cancer survivors.
Philanthropy News
Cult for a Cure champions breast cancer research
After overcoming triple negative breast cancer, Alyssa Tushman and her family champion breast cancer research at U-M's Rogel Cancer Center.
Health Lab
Rare infant triplet overcomes one-in-a-million type of liver cancer
Josephine “JoJo” Wells, a spontaneous triplet, was diagnosed with rare hepatoblastoma at nine months old and treated with surgery and chemotherapy.
